- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| HUNYVERS Aktie jetzt für 0€ handeln |
0 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| GILEAD SCIENCES | 101,14 | +0,20 % | Gilead's Yeztugo, Eisai's Leqembi Iqlik, Vertex's Journavx among 2025's best inventions: Time | ||
| CANOPY GROWTH | 1,204 | +1,69 % | Canopy Growth Corp (2): Canopy's DOJA facility now a medical cultivation site | ||
| MERCK & CO | 74,20 | +0,14 % | Merck Sharp & Dohme: Merck Advances Oncology Innovation, Highlighting Progress in New Tumor Types and Earlier Stages of Disease at ESMO 2025 | Positive survival data from KEYNOTE-905 and KEYNOTE-B96 to be featured in Presidential Symposium, underscoring the impact of KEYTRUDA (pembrolizumab) in certain bladder and ovarian cancers Data... ► Artikel lesen | |
| HALO COLLECTIVE | 0,010 | 0,00 % | Waters Corporation Buys Halo Labs | WASHINGTON (dpa-AFX) - Waters Corporation (WAT), an analytical instruments and software firm, said on Wednesday that it has acquired Halo Labs, a company focused on specialized imaging technologies... ► Artikel lesen | |
| JAGUAR HEALTH | 2,070 | -10,00 % | Jaguar Health, Inc.: Jaguar Health Completes Meeting with FDA for Advice on Development Pathways to Advance Ongoing Crofelemer Trial for Potential Approval for Treatment of Pediatric Indication Microvillus Inclusion Disease | Additional update: Results of ongoing investigator-initiated proof-of-concept trial in United Arab Emirates (UAE) demonstrate further reduction of total parenteral support (PS) (comprised of total parenteral... ► Artikel lesen | |
| MADRIGAL PHARMACEUTICALS | 372,40 | +0,73 % | Madrigal Pharmaceuticals, Inc.: Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) | CONSHOHOCKEN, Pa., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated... ► Artikel lesen | |
| IQVIA | 173,10 | +1,41 % | HSBC stuft IQVIA auf "Buy" hoch: Nachlassender Regulierungsdruck als Hauptgrund | ||
| INTERCEPT PHARMACEUTICALS | - | - | Long Regulatory Saga for Intercept Pharma Liver Drug Ends a Decade After Speedy FDA Approval | ||
| AZENTA | 25,600 | -0,78 % | Azenta Reports Third Quarter Results for Fiscal 2025, Ended June 30, 2025; Reiterates Full Year Fiscal 2025 Guidance | BURLINGTON, Mass., Aug. 5, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the third quarter ended June 30, 2025.
... ► Artikel lesen | |
| PROTHENA | 8,750 | +0,57 % | Prothena stock price target raised to $20 from $14 at H.C. Wainwright | ||
| ALMIRALL | 11,960 | +0,34 % | Almirall, S.A.: Almirall Presents Long-Term Results from First Real-World Dermatology Study Using WHO-5 Well-Being Index as Primary Endpoint in the treatment of Psoriasis at EADV 2025 | Results of the POSITIVE study assessing the treatment with tildrakizumab showed sustained improvements in skin clearance, psychological well-being, and improved partner quality of life in adults... ► Artikel lesen | |
| FUJI PHARMA | 8,800 | 0,00 % | Dividendenbekanntmachungen (29.09.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACADIAN TIMBER CORP CA0042721005 0,29 CAD 0,1777 EUR ACOM CO LTD JP3108600002 10 JPY 0,0572 EUR ADVANTEST CORPORATION JP3122400009 19... ► Artikel lesen | |
| FINANCIERE DE TUBIZE | 239,00 | +2,58 % | Financière de Tubize SA: Financière de Tubize strengthens its expertise in the biopharma field by appointing 2 new directors | Since the appointment of Bruno Holthof as Chairman of the Board of Directors of the company in April 2025, the company's board has continued to strengthen its expertise in the biopharma field. This... ► Artikel lesen | |
| BAYER | 27,980 | -0,78 % | DAX fest, Gold, Bitcoin, Nikkei mit Rekorden: Redcare, Nordex, Merck, Siemens Energy, Bayer ... | Der DAX hat sich am Freitag nach einer starken Woche bei 24.378,80 Punkten ins Wochenende verabschiedet. Auf Wochensicht konnte er 2,7 Prozent zulegen. Zum Start in die neue Woche dürfte es noch ein... ► Artikel lesen | |
| MERCK KGAA | 116,10 | -1,74 % | Unilever Appoints Merck CEO Belén Garijo López as Independent Non-Executive Director |
HUNYVERS SA gehört der Branche Pharma an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 7,120 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu HUNYVERS SA finden Sie auf Wallstreet Online.